Clinical Trials List
2023-06-01 - 2026-12-31
Phase III
Not yet recruiting3
Recruiting6
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Wei- Chang Huang 無
- 王俊隆 無
- 張可昀 無
- 李柏昕 無
- 趙文震 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ming-Ju Tsai 無
- 蔡毓真 無
- Hung-Ling Huang 無
- 鄭孟軒 無
- 莊政皓 無
- 陳家閔 無
- Wei-An Chang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 郭書𡵓 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃鴻育 無
- 萬永亮 無
- Fu-Tsai Chung 無
- Wan-Jing Ho 無
- 羅君禹 無
- 林倡葦 無
- Horng-Chyuan Lin 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ping-Hung Kuo Division of Thoracic Medicine
- 鄭之勛 Division of Thoracic Medicine
- 許嘉林 Division of Thoracic Medicine
- 黃俊凱 Division of Thoracic Medicine
- 張允中 Division of Thoracic Medicine
- 賀立婷 Division of Thoracic Medicine
- Jung-Yien Chien Division of Thoracic Medicine
- 郭耀文 Division of Thoracic Medicine
- 錢穎群 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
2120 participants
